Literature DB >> 12480856

Beta blockers for glaucoma and excess risk of airways obstruction: population based cohort study.

James F Kirwan1, Julia A Nightingale, Catey Bunce, Richard Wormald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12480856      PMCID： PMC138518          DOI： 10.1136/bmj.325.7377.1396

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  The impact of new drugs on management of glaucoma in Scotland: observational study.

Authors:  D N Bateman; R Clark; A Azuara-Blanco; M Bain; J Forrest
Journal:  BMJ       Date:  2001-12-15

2.  Effect of timolol 0.5% gel and solution on pulmonary function in older glaucoma patients.

Authors:  W C Stewart; D G Day; K T Holmes; J A Stewart
Journal:  J Glaucoma       Date:  2001-06       Impact factor: 2.503

3.  Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents.

Authors:  P Diggory; A Cassels-Brown; A Vail; L M Abbey; J S Hillman
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

4.  Pulmonary effects of topical timolol.

Authors:  N B Charan; S Lakshminarayan
Journal:  Arch Intern Med       Date:  1980-06

5.  Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage.

Authors:  H A Quigley; J M Tielsch; J Katz; A Sommer
Journal:  Am J Ophthalmol       Date:  1996-09       Impact factor: 5.258
  5 in total
  6 in total

1.  Treatment of raised intraocular pressure and prevention of glaucoma.

Authors:  R Wormald
Journal:  BMJ       Date:  2003-04-05

2.  The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003.

Authors:  C G Owen; I M Carey; S De Wilde; P H Whincup; R Wormald; D G Cook
Journal:  Br J Ophthalmol       Date:  2006-07       Impact factor: 4.638

3.  Do selective topical beta antagonists for glaucoma have respiratory side effects?

Authors:  J F Kirwan; J A Nightingale; C Bunce; R Wormald
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

4.  A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.

Authors:  Tali Fishman Jacob; Vijay Singh; Mudit Dixit; Tamar Ginsburg-Shmuel; Begoña Fonseca; Jesus Pintor; Moussa B H Youdim; Dan T Major; Orly Weinreb; Bilha Fischer
Journal:  Purinergic Signal       Date:  2018-07-17       Impact factor: 3.765

5.  Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.

Authors:  Gus Gazzard; Evgenia Konstantakopoulou; David Garway-Heath; Anurag Garg; Victoria Vickerstaff; Rachael Hunter; Gareth Ambler; Catey Bunce; Richard Wormald; Neil Nathwani; Keith Barton; Gary Rubin; Marta Buszewicz
Journal:  Lancet       Date:  2019-03-09       Impact factor: 79.321

6.  Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users.

Authors:  Wishal D Ramdas; Nathalie van der Velde; Tischa J M van der Cammen; Roger C W Wolfs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-19       Impact factor: 3.117
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.